Table 2.
Covariate-adjusted linear regressions of maternal 25(OH)D3 concentrations categorized as quartiles and neurodevelopmental outcomes (N = 252).
| Neurodevelopmental outcome measure | Quartile | Difference vs. Q1 (95% CI) | p-value | Overall F (df) | Overall p-value | Partial eta squared |
|---|---|---|---|---|---|---|
| WPPSI-IVCDN FSIQ | – | – | – | 2.96 (3, 201) | 0.03* | 0.04 |
| Q1 | Reference | – | – | – | – | |
| Q2 | 11.79 (3.05, 20.5) | 0.008 | – | – | – | |
| Q3 | 0.30 (−7.61, 8.21) | 0.94 | – | – | – | |
| Q4 | 7.43 (−0.31, 15.17) | 0.06 | – | – | – | |
| NEPSY-II Phonological Processing | – | – | – | 0.75 (3, 231) | 0.53 | 0.01 |
| Q1 | Reference | – | – | – | – | |
| Q2 | −0.19 (−1.83, 1.45) | 0.82 | – | – | – | |
| Q3 | 0.08 (−2.04, 2.19) | 0.94 | – | – | – | |
| Q4 | −1.40 (−3.40, 0.60) | 0.17 | – | – | – | |
| NEPSY-II Speeded Naming | – | – | – | 0.53 (3, 153) | 0.67 | 0.01 |
| Q1 | Reference | – | – | – | – | |
| Q2 | 0.32 (−1.69, 2.33) | 0.75 | – | – | – | |
| Q3 | −0.57 (−2.65, 1.51) | 0.59 | – | – | – | |
| Q4 | 0.12 (−1.70, 1.93) | 0.90 | – | – | – | |
| MABC-II Total | – | – | – | 0.52 (3, 232) | 0.67 | 0.01 |
| Q1 | Reference | – | – | – | – | |
| Q2 | 0.22 (−1.30, 1.75) | 0.78 | – | – | – | |
| Q3 | −0.81 (−2.82, 1.19) | 0.43 | – | – | – | |
| Q4 | 0.56 (−1.34, 2.45) | 0.54 | – | – | – | |
| BASC-II Internalizing Problems | – | – | – | 0.75 (3, 175) | 0.52 | 0.01 |
| Q1 | Reference | – | – | – | – | |
| Q2 | 2.82 (−2.16, 7.79) | 0.27 | – | – | – | |
| Q3 | 0.28 (−4.65, 5.21) | 0.91 | – | – | – | |
| Q4 | 2.42 (−2.05, 6.89) | 0.29 | – | – | – | |
| BASC-II Externalizing Problems | – | – | – | 0.80 (3, 201) | 0.50 | 0.01 |
| Q1 | Reference | – | – | – | – | |
| Q2 | 3.10 (−2.49, 8.69) | 0.28 | – | – | – | |
| Q3 | 3.54 (−1.52, 8.60) | 0.17 | – | – | – | |
| Q4 | 2.13 (−2.82, 7.08) | 0.40 | – | – | – |
Covariates are the same as those included in the linear regressions of continuous maternal 25(OH)D3 concentrations and neurodevelopmental outcomes.
*p < 0.05.